Not Medicare Enrolled

Dr. Lexie Willingham, FNP

Nurse Practitioner - Family · Midland, TX
Low-engagement
3305 ANDREWS HWY, Midland, TX 79703
4326200525
In practice since 2020 (5 years)
NPI: 1164038576 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Willingham from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Willingham? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Willingham

Dr. Lexie Willingham is a nurse practitioner - family in Midland, TX, with 5 years of NPI registration.

Between the years covered by Open Payments, Dr. Willingham received a total of $7,179 from 37 pharmaceutical and/or device companies across 439 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Willingham is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 5 years in practice $7,179 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$7,179
Total received (2021-2024)
Avg $1,795/year across 4 years
Top 2% in TX for nurse practitioner - family
37
Companies
439
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,179 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,905
2023
$1,733
2022
$2,290
2021
$1,250

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,057
Amgen Inc.
$931
AstraZeneca Pharmaceuticals LP
$907
Lilly USA, LLC
$807
Novo Nordisk Inc
$569
Astellas Pharma US Inc
$443
PFIZER INC.
$346
Boehringer Ingelheim Pharmaceuticals, Inc.
$319
GlaxoSmithKline, LLC.
$315
AbbVie Inc.
$247
Antares Pharma, Inc.
$144
SANOFI-AVENTIS U.S. LLC
$133
Takeda Pharmaceuticals U.S.A., Inc.
$128
Biohaven Pharmaceutical Holding Company Ltd.
$120
Novartis Pharmaceuticals Corporation
$68
EISAI INC.
$64
Otsuka America Pharmaceutical, Inc.
$60
Janssen Pharmaceuticals, Inc
$54
Paratek Pharmaceuticals, Inc.
$49
Xeris Pharmaceuticals, Inc.
$46
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$43
IDORSIA PHARMACEUTICALS US INC
$32
Kowa Pharmaceuticals America, Inc.
$31
Axonics, Inc.
$29
Phathom Pharmaceuticals, Inc.
$29
Teva Pharmaceuticals USA, Inc.
$28
Exact Sciences Corporation
$23
Supernus Pharmaceuticals, Inc.
$20
Currax Pharmaceuticals LLC
$19
Bayer Healthcare Pharmaceuticals Inc.
$19
Amarin Pharma Inc.
$18
kaleo, Inc.
$16
E.R. Squibb & Sons, L.L.C.
$14
Merck Sharp & Dohme LLC
$14
ARBOR PHARMACEUTICALS, INC.
$13
Merck Sharp & Dohme Corporation
$13
Eisai Inc.
$12
Top 3 companies account for 40.3% of total payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · AJOVY · AREXVY · AUVI-Q · Aimovig · Axonics · BELSOMRA · BOTOX · BREZTRI · COMIRNATY · CONTRAVE · Cologuard Collection Kit · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbyclor · FARXIGA · FASENRA · GVOKE PFS · JARDIANCE · KEVEYIS · Kerendia · LEQVIO · LINZESS · Livalo · MOUNJARO · Myrbetriq · NOCDURNA · NURTEC ODT · NUZYRA · Otezla · Ozempic · PAXLOVID · PREVNAR 13 · PREVNAR 20 · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SOLIQUA 100/33 · SYNJARDY · SYNTHROID · Saxenda · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Wegovy · XARELTO · XIFAXAN · XYOSTED · ZEPBOUND · ZORYVE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for nurse practitioner - family in TX.

Looking for a nurse practitioner - family in Midland?
Compare family nurse practitioners in the Midland area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
222
Per 100K population
129.4
County median income
$93,984
Nearest hospital
MIDLAND MEMORIAL HOSPITAL
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Willingham is a nurse practitioner - family, with low-engagement industry engagement in the top 2% of TX peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Willingham receive payments from pharmaceutical companies?
Yes. Dr. Willingham received a total of $7,179 from 37 companies across 439 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Willingham) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →